Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 6Phase 3 4Phase 1/2 3Phase 2/3 1

Status

Completed 5Unknown 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 6OTHER_GOV 1OTHER 1

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 2Thoracic 1

Conditions

Breast Neoplasms 144Neoplasm Metastasis 16Neoplasms 8Advanced Breast Cancer 8Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Cancer Metastatic 5Prostatic Neoplasms 4Endometrial Neoplasms 4Recurrence 3Hereditary Sensory and Autonomic Neuropathies 3Lung Neoplasms 2Hyperglycemia 2Exanthema 2Estrogen Receptor-positive Breast Cancer 2Colorectal Neoplasms 2Carcinoma, Lobular 2Breast Neoplasms, Male 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Endometrial Stromal 1Salivary Gland Neoplasms 1Recurrent Uterine Corpus Carcinoma 1Neoplastic Cells, Circulating 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Fulvestrant × Clear all
NCT06979596 2026-05-13

OMAHA-015

Merck Sharp & Dohme LLC

Phase 2 Recruiting
250 enrolled
Tumor-Agnostic

Neoplasms

NCT01953926 2024-03-12

SUMMIT

Puma Biotechnology, Inc.

Phase 2 Terminated
582 enrolled 27 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT00313170 2020-01-06

FINDER II

AstraZeneca

Phase 2 Completed
144 enrolled 15 charts
Breast

Breast Neoplasms, Neoplasms

NCT00274469 2019-09-06

FIRST

AstraZeneca

Phase 2 Completed
205 enrolled 13 charts
Breast

Breast Neoplasms, Neoplasms

NCT02530411 2015-08-21

FURVA

Velindre NHS Trust

Phase 2 Unknown
160 enrolled
Tumor-Agnostic

Neoplasms

NCT00534417 2013-02-01

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Accelerated Community Oncology Research Network

Phase 2 Completed
41 enrolled 13 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00305448 2012-02-15

FINDER I

AstraZeneca

Phase 2 Completed
143 enrolled 12 charts
Breast

Breast Neoplasms, Neoplasms

NCT00357110 2010-12-21

@FAME

AstraZeneca

Phase 2 Completed
13 enrolled 7 charts
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡